Tesleem Olatunde Abolarinwa

Tesleem Olatunde Abolarinwa

Auto-generated profile, based on publicly available information

Tesleem Olatunde Abolarinwa

Department of Botany and Plant Biotechnology, University of Johannesburg, PO Box 524, 2006, Auckland Park, Johannesburg, South Africa

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2022 in Frontiers in Microbiology
Verified
Journal Article
Open access
TATesleem Olatunde Abolarinwa
Tesleem Olatunde Abolarinwa
DADaniel Jesuwenu Ajose
Daniel Jesuwenu Ajose
BOBukola Opeyemi Oluwarinde
Bukola Opeyemi Oluwarinde
JFJustine Fri
Justine Fri
KMKotsoana Peter Montso
Kotsoana Peter Montso
CACollins Ateba
Collins Ateba
Diarrhea is a condition in which feces is discharged from the bowels frequently and in a liquid form. It is one of the frequent causes of morbidity and mortality in developing countries. The impact of Diarrhea is worsened by the increasing incidence of antimicrobial resistance among the causative agents, and this is now categorized as a global healthcare challenge. Antimicrobial resistance among Diarrheal pathogens also contributes to extended infection durations, and huge economic loss even in countries with advanced public health policies. The ever-increasing incidence of antimicrobial resistance including the contraindications arising from the administration of antibiotics in some Diarrheal cases highlights a crucial need for the development of novel non-antibiotic alternative agents for therapeutic and biocontrol applications. One such intervention includes the application of plant-derived nanoparticles (PDNPs) with novel antimicrobial properties. Given their small size and large surface area to volume ratio, PDNPs can attack target bacterial cell walls to generate reactive oxygen species that may simultaneously disrupt bacteria cell components such as DNA and proteins leading to cell damage or death. This potential can make it very difficult for pathogenic organisms to develop resistance against these antibacterial agents. In this review, we provide a critical overview on the antimicrobial resistance crisis among Diarrheagenic bacteria. We also discuss the evidence from the existing literature to support the potential associated with the use of PDNPs as alternative therapeutic agents for multidrug resistant and antibiotics administer contraindicated bacteria that are associated with Diarrhea.

1 January 2025 in International Journal of Microbiology
Verified
Journal Article
Open access
BOBukola Opeyemi Oluwarinde
Bukola Opeyemi Oluwarinde
DADaniel Jesuwenu Ajose
Daniel Jesuwenu Ajose
TATesleem Olatunde Abolarinwa
Tesleem Olatunde Abolarinwa
PMPeter Kotsoana Montso
Peter Kotsoana Montso
HNHenry Njom
Henry Njom
CACollins Ateba
Collins Ateba
Antimicrobial‐resistant Escherichia coli , especially those belonging to the serotype O157, are increasingly linked to foodborne diseases with significant fatality rates worldwide. The food and medical industries have focused on E. coli O157:H7 due to its ability to produce toxins coupled with its low infectious dose. The aim of this study was to assess the virulome, resistome, and pathogenicity of E. coli O157:H7 using whole genome sequencing. Three previously isolated E. coli O157:H7 strains from cattle feces were subjected to whole genome sequencing. The genome sizes of all three E. coli O157:H7 strains were 5,117,276 bp, 5,039,443 bp, and 5,034,351 bp. The C + G contents were 50.22%, 50.53%, and 50.54%, while the number of contigs was 110, 43, and 42, respectively, for E. coli O157:H7 strains J32, J57, and J69. Several virulence determinants (hemorrhagic E. coli pilus (HCP), eaeA, hemolysin, etc.) were found in the genomes of these isolates. In addition, antibiotic resistance genes conferring resistance to aminoglycosides, tetracyclines, macrolides, fluoroquinolones, penams, carbapenems, cephalosporins, cephamycin, rifamycin, phenicols, monobactams, and nitroimidazole were found in the genomes. Interestingly, the genomes of these isolates also harbored determinants encoding resistance to disinfectants and antiseptics, indicating their concern in the food production and medical sectors. This highlights the public health concerns of these isolates, indicating the need for constant surveillance.

10 November 2025 in Nano Express
Verified
Journal Article
Open access
LMLerato D Msimango
Lerato D Msimango
TATesleem O Abolarinwa
Tesleem O Abolarinwa
OOOlusola Ojelere
Olusola Ojelere
MOMercy Chisara Ogwuegbu
Mercy Chisara Ogwuegbu
Doctor Mziwenkosi Nhlanhla MthiyaneDoctor Mziwenkosi Nhlanhla Mthiyane
Doctor Mziwenkosi Nhlanhla Mthiyane
DODamian Onwudiwe
Damian Onwudiwe
The green synthesis approach, employing eco-friendly methods, offers a sustainable and environmentally benign alternative to conventional synthesis routes by minimising toxic by-products and energy consumption. This study presents the green synthesis, structural characterization, and antibacterial evaluation of copper oxide (CuO) nanoparticles, denoted as CuO(1), CuO(2), and CuO(3), synthesised using copper nitrate (Cu(NO 3 ) 2 ), copper acetate (Cu(CH 3 COO) 2 ), and copper sulfate (CuSO 4 ), respectively. Structural characterisation showed that the choice of precursor salt significantly influenced the crystallite size, lattice parameters, and porosity of the resulting nanoparticles. CuO(3) exhibited the largest crystallite size (76.73 nm) and the lowest surface area (0.0120 m 2 g −1 ), while CuO(1) had the smallest crystallite size (35.78 nm) and the highest surface area (0.0258 m 2 g −1 ). All samples showed spherical morphology as confirmed by microscopic analysis. The synthesised CuO(1), CuO(2), and CuO(3) nanoparticles exhibited antibacterial activity against Staphylococcus aureus, Streptococcus pyogenes , Escherichia coli, and Pseudomonas aeruginosa with MIC values ranging from 0.031 to 0.25, 0.062 to 0.50, and 0.062 to 0.50 mg ml −1 , respectively. These results highlight the potential of precursor-dependent tuning of CuO nanoparticles for enhanced antibacterial applications using green synthesis strategies.

1 March 2026 in Nano Express
Verified
Journal Article
Open access
KMKeotshepile A Malebadi
Keotshepile A Malebadi
TATesleem O Abolarinwa
Tesleem O Abolarinwa
NSNaledi H Seheri
Naledi H Seheri
CAChahra Amairia
Chahra Amairia
DODamian Onwudiwe
Damian Onwudiwe
This study presents the use of extracts of Searsia lancea in the synthesis of zinc oxide nanoparticles (ZnONPs), silver nanoparticles (AgNPs), and silver-doped zinc oxide nanocomposites (Ag/ZnO) at different dopant concentrations of 0, 1, 5, 10, and 20%, given composites denoted as 1%Ag/ZnO, 5%Ag/ZnO, 10%Ag/ZnO, and 20%Ag/ZnO, respectively. The synthesized ZnONPs, AgNPs, and Ag/ZnO nanocomposites were characterized using spectroscopic and microscopic techniques, and their antibacterial activities were evaluated against common bacterial pathogens. The UV–vis spectroscopy and XRD results reveal successful formation of ZnONPs, AgNPs, and Ag/ZnO nanocomposites with improved structural and optical properties. The TEM results confirmed particle sizes of 49.75, 32.91, 30.95, 29.29, and 26.00 nm for 1%Ag/ZnO, 5%Ag/ZnO, 10%Ag/ZnO, and 20%Ag/ZnO, respectively, indicating a decrease in particle size with increasing Ag ion concentration. The pure AgNPs showed strong antibacterial activity, with MIC values of 0.25 mg ml −1 against E. coli and P. aeruginosa , and 0.062 mg ml −1 against S. aureus and S. pyogenes . In contrast, pristine ZnONPs (0%Ag/ZnO) exhibited higher MIC values of 1.00, 0.50, 0.25, and 0.25 mg ml −1 against E. coli , P. aeruginosa , S. aureus and S. pyogenes , respectively. Notably, 1%Ag/ZnO and 5%Ag/ZnO nanocomposites displayed moderate activity, with MIC values in the range 0.125 to 0.50 mg ml −1 across all strains. The 10%Ag/ZnO nanocomposite showed consistent MIC values of 0.125 mg ml −1 for all tested organisms. The 20%Ag/ZnO nanocomposite exhibited the highest antibacterial potency among all synthesized samples, with MIC values of 0.062 mg ml −1 against E. coli and P. aeruginosa , and 0.031 mg ml −1 against S. aureus and S. pyogenes. The enhanced antibacterial activities shown by Ag/ZnO nanocomposites compared to pure ZnONPs, with efficiency increasing with the concentration of Ag highlights the potential of plant-mediated silver-doped zinc oxide nanocomposites as eco-friendly and efficient antimicrobial agents.